华益泰康药业股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
15
NMPA:15
Drug Approvals
Polyethylene Glycol (3350) and Electrolytes Powder
- Product Name
- 复方聚乙二醇(3350)电解质散
- Approval Number
- 国药准字H20254388
- Approval Date
- May 27, 2025
NMPA
Paroxetine Hydrochloride Enteric-Coated Sustained-Release Tablets
- Product Name
- 盐酸帕罗西汀肠溶缓释片
- Approval Number
- 国药准字H20247259
- Approval Date
- Oct 29, 2024
NMPA
Esomeprazole Magnesium Enteric-coated Capsules
- Product Name
- 艾司奥美拉唑镁肠溶胶囊
- Approval Number
- 国药准字H20244322
- Approval Date
- Jun 28, 2024
NMPA
Esomeprazole Magnesium Enteric-coated Capsules
- Product Name
- 艾司奥美拉唑镁肠溶胶囊
- Approval Number
- 国药准字H20244321
- Approval Date
- Jun 28, 2024
NMPA
Paroxetine Hydrochloride Enteric-Coated Sustained-Release Tablets
- Product Name
- 盐酸帕罗西汀肠溶缓释片
- Approval Number
- 国药准字H20233334
- Approval Date
- Mar 24, 2023
NMPA
Levocetirizine Dihydrochloride Oral Solution
- Product Name
- 盐酸左西替利嗪口服溶液
- Approval Number
- 国药准字H20183156
- Approval Date
- Mar 14, 2023
NMPA
Levocetirizine Dihydrochloride Oral Solution
- Product Name
- 盐酸左西替利嗪口服溶液
- Approval Number
- 国药准字H20183155
- Approval Date
- Mar 14, 2023
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found